← Every applicant
Exela Pharma FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ACETYLCYSTEINENew drugNov 1, 2023SOLUTION, INHALATION, ORAL |
| FENTANYL CITRATENew drugFeb 8, 2023SOLUTION, INTRAVENOUS |
| CUPRIC CHLORIDENew drugOct 31, 2022INJECTABLE, INJECTION |
| MIDAZOLAM IN 0.8% SODIUM CHLORIDENew drugJul 20, 2022SOLUTION, INTRAVENOUS |
| DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%New drugOct 28, 2021SOLUTION, INTRAVENOUS |
| POTASSIUM ACETATENew drugOct 20, 2021INJECTABLE, INJECTION |
| ZINC CHLORIDENew drugMay 21, 2021INJECTABLE, INJECTION |
| ACETYLCYSTEINENew drugApr 15, 2021INJECTABLE, INTRAVENOUS |